| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | 5-diphosphoinositol pentakisphosphate 1-kinase activity | 3.91e-06 | 2 | 40 | 2 | GO:0033857 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate 3-kinase activity | 2.34e-05 | 4 | 40 | 2 | GO:0052724 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate 1-kinase activity | 2.34e-05 | 4 | 40 | 2 | GO:0052723 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate 5-kinase activity | 3.90e-05 | 5 | 40 | 2 | GO:0000832 | |
| GeneOntologyMolecularFunction | diphosphoinositol pentakisphosphate kinase activity | 3.90e-05 | 5 | 40 | 2 | GO:0000829 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate kinase activity | 3.90e-05 | 5 | 40 | 2 | GO:0000828 | |
| GeneOntologyMolecularFunction | inositol-1,3,4,5,6-pentakisphosphate kinase activity | 3.90e-05 | 5 | 40 | 2 | GO:0000827 | |
| GeneOntologyMolecularFunction | inositol phosphate kinase activity | 2.13e-04 | 11 | 40 | 2 | GO:0180030 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, phosphate group as acceptor | 3.05e-03 | 41 | 40 | 2 | GO:0016776 | |
| GeneOntologyBiologicalProcess | inositol phosphate biosynthetic process | 2.92e-05 | 31 | 40 | 3 | GO:0032958 | |
| Domain | Acid_Pase_AS | 6.67e-05 | 6 | 40 | 2 | IPR033379 | |
| Domain | HIS_ACID_PHOSPHAT_2 | 9.33e-05 | 7 | 40 | 2 | PS00778 | |
| Domain | HIS_ACID_PHOSPHAT_1 | 9.33e-05 | 7 | 40 | 2 | PS00616 | |
| Domain | His_Pase_clade-2 | 1.24e-04 | 8 | 40 | 2 | IPR000560 | |
| Domain | His_Phos_2 | 1.24e-04 | 8 | 40 | 2 | PF00328 | |
| Domain | His_PPase_superfam | 8.29e-04 | 20 | 40 | 2 | IPR029033 | |
| Domain | - | 8.29e-04 | 20 | 40 | 2 | 3.40.50.1240 | |
| Domain | HECT | 1.52e-03 | 27 | 40 | 2 | PF00632 | |
| Domain | HECTc | 1.52e-03 | 27 | 40 | 2 | SM00119 | |
| Domain | HECT_dom | 1.52e-03 | 27 | 40 | 2 | IPR000569 | |
| Domain | HECT | 1.52e-03 | 27 | 40 | 2 | PS50237 | |
| Domain | FYVE | 1.75e-03 | 29 | 40 | 2 | PF01363 | |
| Domain | FYVE | 1.75e-03 | 29 | 40 | 2 | SM00064 | |
| Domain | Znf_FYVE-rel | 2.40e-03 | 34 | 40 | 2 | IPR017455 | |
| Domain | Znf_FYVE | 2.99e-03 | 38 | 40 | 2 | IPR000306 | |
| Domain | ZF_FYVE | 3.31e-03 | 40 | 40 | 2 | PS50178 | |
| Domain | - | 4.81e-03 | 321 | 40 | 4 | 3.80.10.10 | |
| Domain | L_dom-like | 5.19e-03 | 328 | 40 | 4 | IPR032675 | |
| Domain | MFS | 1.18e-02 | 77 | 40 | 2 | IPR011701 | |
| Domain | MFS_1 | 1.18e-02 | 77 | 40 | 2 | PF07690 | |
| Pathway | REACTOME_SYNTHESIS_OF_PYROPHOSPHATES_IN_THE_CYTOSOL | 2.36e-04 | 10 | 33 | 2 | M27051 | |
| Pathway | REACTOME_SYNTHESIS_OF_PYROPHOSPHATES_IN_THE_CYTOSOL | 2.36e-04 | 10 | 33 | 2 | MM14709 | |
| Pathway | REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION | 6.05e-04 | 299 | 33 | 5 | MM15711 | |
| Pathway | REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION | 6.92e-04 | 308 | 33 | 5 | M1070 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 28126903 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 18981179 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 17690096 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 17702752 | ||
| Pubmed | Autoregulation of the 26S proteasome by in situ ubiquitination. | 1.45e-06 | 19 | 41 | 3 | 24743594 | |
| Pubmed | 1.99e-06 | 21 | 41 | 3 | 37422473 | ||
| Pubmed | PPIP5K2 and PCSK1 are Candidate Genetic Contributors to Familial Keratoconus. | 4.06e-06 | 3 | 41 | 2 | 31852976 | |
| Pubmed | TRIM26 promotes non-small cell lung cancer survival by inducing PBX1 degradation. | 8.12e-06 | 4 | 41 | 2 | 37324936 | |
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 28425671 | ||
| Pubmed | 3.78e-05 | 8 | 41 | 2 | 37871017 | ||
| Pubmed | Characterization of human hect domain family members and their interaction with UbcH5 and UbcH7. | 4.86e-05 | 9 | 41 | 2 | 9575161 | |
| Pubmed | Autoubiquitination of the 26S proteasome on Rpn13 regulates breakdown of ubiquitin conjugates. | 6.61e-05 | 66 | 41 | 3 | 24811749 | |
| Pubmed | 1.05e-04 | 13 | 41 | 2 | 20164180 | ||
| Pubmed | The ubiquitin ligase TRIM25 targets ERG for degradation in prostate cancer. | 1.22e-04 | 14 | 41 | 2 | 27626314 | |
| Pubmed | 1.22e-04 | 14 | 41 | 2 | 12739169 | ||
| Pubmed | Assembly and structure of Lys33-linked polyubiquitin reveals distinct conformations. | 1.61e-04 | 16 | 41 | 2 | 25723849 | |
| Pubmed | Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity. | 1.95e-04 | 95 | 41 | 3 | 29643511 | |
| Pubmed | 2.55e-04 | 104 | 41 | 3 | 9205841 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 2.80e-04 | 1105 | 41 | 7 | 35748872 | |
| Pubmed | PRDM16 expression and function in mammalian cochlear development. | 3.38e-04 | 23 | 41 | 2 | 35451126 | |
| Pubmed | System-Wide Modulation of HECT E3 Ligases with Selective Ubiquitin Variant Probes. | 4.33e-04 | 26 | 41 | 2 | 26949039 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 5.01e-04 | 313 | 41 | 4 | 38270169 | |
| Pubmed | 5.03e-04 | 28 | 41 | 2 | 35474067 | ||
| Pubmed | 6.17e-04 | 31 | 41 | 2 | 23895693 | ||
| Pubmed | Identification of phagocytosis regulators using magnetic genome-wide CRISPR screens. | 6.47e-04 | 143 | 41 | 3 | 30397336 | |
| Pubmed | 6.58e-04 | 32 | 41 | 2 | 36278411 | ||
| Pubmed | TRIP12 promotes small-molecule-induced degradation through K29/K48-branched ubiquitin chains. | 7.00e-04 | 33 | 41 | 2 | 33567268 | |
| Pubmed | 7.05e-04 | 606 | 41 | 5 | 36538041 | ||
| Pubmed | 8.33e-04 | 36 | 41 | 2 | 35379950 | ||
| Pubmed | 1.10e-03 | 172 | 41 | 3 | 27375898 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q16 | 1.16e-03 | 56 | 41 | 2 | chr6q16 | |
| GeneFamily | Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors | 1.05e-03 | 31 | 28 | 2 | 81 | |
| Computational | Genes in the cancer module 478. | 3.96e-04 | 19 | 17 | 2 | MODULE_478 | |
| Disease | peptide measurement | 4.39e-04 | 109 | 40 | 3 | EFO_0010520 | |
| Disease | arginine measurement | 4.45e-04 | 23 | 40 | 2 | EFO_0020990 | |
| Disease | cerebrospinal fluid clusterin measurement | 1.04e-03 | 35 | 40 | 2 | EFO_0007657 | |
| Disease | erectile dysfunction | 1.49e-03 | 42 | 40 | 2 | EFO_0004234 | |
| Disease | HETE measurement | 3.22e-03 | 62 | 40 | 2 | EFO_0801166 | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 4.16e-03 | 239 | 40 | 3 | EFO_0010934 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LHFLHSLASSSSLIY | 36 | A8MVM7 | |
| AALLSTTHETLIHFY | 2051 | Q96PZ7 | |
| SIYHLASYLAFSLSH | 1596 | Q86UQ4 | |
| SGLSSYHLKTALLHL | 426 | Q8IWB1 | |
| HSYLTDTLHSLISEL | 156 | Q9UQ53 | |
| SLQSTVHYHLGSLAL | 96 | P30989 | |
| TSIFHTFSHSYLELK | 451 | Q8TDN1 | |
| SLSIHAYHSFSTGLS | 191 | Q8NA75 | |
| HLTESVLYHLTSSIS | 3501 | Q5CZC0 | |
| HSFTLHTLLTYATRD | 1241 | O95382 | |
| SLGAESHLSLLYHLT | 21 | P55899 | |
| SHLSLLYHLTAVSSP | 26 | P55899 | |
| TQHTHTLLSYVHFLL | 276 | Q8NGJ8 | |
| HLYSSIEHLTTLLAS | 111 | Q7Z6Z7 | |
| SLAHLETLSHSFILS | 1961 | A2RRP1 | |
| TLGHLLSLDSYRTTH | 501 | Q02809 | |
| VLLIAHYSFLSHTST | 331 | P25116 | |
| SHFLSSHLIIDYSLL | 2006 | Q9Y2I7 | |
| IGTTHFIYSNLLHST | 1536 | Q6WRI0 | |
| CHYSTLAFSLLAHVL | 176 | A8MY62 | |
| SLSSLRAHLEYSHTY | 21 | Q8TF61 | |
| LLYTLTTAFTLAHIH | 346 | Q9C0D9 | |
| LLTSFSSLLFYICSH | 156 | Q96CH1 | |
| LLVHSKLLAFYSSHS | 211 | Q92902 | |
| LTLHPASSSLHYSLQ | 86 | O15382 | |
| LHLSFYLTSIYDHSI | 211 | Q9HB90 | |
| HLFYSSLLACISLHS | 6 | Q9H5Y7 | |
| LSSFATSLKHLYLTL | 131 | Q6ZSM3 | |
| LLVLSYLHVHTALFS | 281 | P08842 | |
| FSSLYSFSDVLHHLI | 306 | Q96PL2 | |
| SNHYSLLTSSASIVH | 6 | P20265 | |
| SYLSSLSHLNNLSHL | 451 | Q9Y2G3 | |
| IHSLSDVTLTLYHSF | 641 | Q86Y38 | |
| AFIDFSSLTSHLRSH | 236 | Q8NEP9 | |
| LASFATSLTHLYLSI | 96 | Q7RTY0 | |
| LYFTSESHVHSLLSI | 821 | O43314 | |
| KSLLASLHTSRSAYH | 2526 | Q5T4S7 | |
| HTSLATSHFLANYLT | 1621 | Q68DK2 | |
| RLYFTSESHVHSLLS | 836 | Q6PFW1 | |
| LHLTSVLLFQFSTHS | 686 | O94874 | |
| FTYSSLLLSHRRIHS | 321 | A8K8V0 | |
| YLFSSLFSHSLISIH | 501 | Q15386 | |
| YLSTSLLHNKSLTHL | 891 | Q86W24 |